CDK8-IN-13 is a CDK8 inhibitor (IC50: 51.9 nM) with potent, selective and oral activity. CDK8-IN-13 induces apoptosis and reduces the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 exhibits anti-tumour activity.
Molecular Weight:
237.26
Purity:
0.9928
CAS Number:
[918523-75-8]
Formula:
C14H11N3O
Target:
Apoptosis|||CDK
* VAT and and shipping costs not included. Errors and price changes excepted